Tumor repolarization by an advanced liposomal drug delivery system provides a potent new approach for chemo-immunotherapy
Lars Ringgaard, Fredrik Melander, Rasmus Eliasen, Jonas R. Henriksen, Rasmus I. Jølck, Trine B. Engel, Martin Bak, Frederikke P. Fliedner, Kasper Kristensen, Dennis Ringkjøbing Elema, Andreas Kjær, Anders E. Hansen, Thomas L. Andresen
Abstract
T helper cells. These results are encouraging toward advancing liposomal drug delivery systems with anticancer and immune-modulating properties into clinical cancer therapy.
Topics & Concepts
ImmunotherapyDrugLiposomeDrug deliveryMedicinePharmacologyComputer scienceComputational biologyBiologyImmunologyNanotechnologyImmune systemMaterials scienceNanoparticle-Based Drug DeliveryImmunotherapy and Immune ResponsesNanoplatforms for cancer theranostics